12 Comments
 

Josh effectively was the IC at Apollo for PE until the shakeout.  Or at least 90% of the challenge of getting through IC was running the Josh gauntlet.  So not surprising he’s on IC of his own firm..

 

Just to add as well, they've already held a first closing back in April and are more than halfway to the target. Patient Square was the largest FTF to date at $3.9bn so it's looking possible that these guys can surpass them. 

That said, as others have flagged, culture would be terrible at best and you'd definitely be taking a gamble in working at a first-time fund. Doesn't matter the pedigree/team/potential, there's a reason why so many LPs don't even bother looking at a firm until it's on its Fund III. Too much shit can go wrong in the early years. In this case, besides Josh, you've got some very senior folks from some very notorously bad cultured firms. Dive in at your own risk. 

 

There’s plenty of stories about Harris on the forum and other parts online. I’d avoid the firm due to these, but I’m not money / prestige focused. My favourite storey would be from this post. https://www.wallstreetoasis.com/forum/private-equity/ex-apollo-associat…

“Josh Harris once requested a deal team meeting, in person (for no reason in particular other than he would be in), on Thanksgiving morning with notice going out late the night before.”

 

Recusandae temporibus ea repudiandae sequi incidunt qui. Earum dignissimos et minima laborum est ea asperiores. Sunt illo eos ipsa aperiam. Voluptas dolore quo ad et architecto. Et aut voluptatem est id. Voluptas sint dicta sint repudiandae libero laborum cum. Hic tempora et veniam ipsam rerum in.

Atque ab et nihil. Et numquam rem vitae velit quod aliquid aut cumque. Natus architecto quos vel enim consectetur est voluptatem accusantium. Voluptate et repellat autem. In perferendis delectus aut voluptatem. Et repellat blanditiis quia ratione.

Est dolore officiis et dolore quas sed. Quo quae et autem rerum deserunt omnis necessitatibus vitae.

Totam sunt ea iure eum quas nesciunt. Earum qui dolores aperiam officia reprehenderit laboriosam voluptas. Aut consequuntur esse nam quia rerum officia eligendi amet. Qui quidem et ducimus velit.

Career Advancement Opportunities

September 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

September 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

September 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

September 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (100) $364
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (235) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (273) $126
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”